MCL Clinical Trials
1230 trials from ClinicalTrials.gov. Recruiting trials shown first.
Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
COMPLETEDNCT00304018·PHASE1·University of California, San Francisco·5 enrolled
anti-thymocyte globulinsargramostimbusulfanetoposidefludarabine phosphate+4 more
Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell Lymphoma
COMPLETEDNCT00053092·PHASE2·Institute of Cancer Research, United Kingdom·82 enrolled
rituximabcyclophosphamidefludarabine phosphate
VNP40101M in Treating Patients With Advanced or Metastatic Cancer
COMPLETEDNCT00049699·PHASE1·Vion Pharmaceuticals
laromustine
Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Colon Cancer That Has Not Responded to Vaccine Therapy
COMPLETEDNCT00047164·PHASE1·National Institutes of Health Clinical Center (CC)·89 enrolled
ipilimumab
S0213 Chemotherapy Plus Rituximab in Treating Patients With Mantle Cell Lymphoma
COMPLETEDNCT00041132·PHASE2·SWOG Cancer Research Network·56 enrolled
filgrastimrituximabcyclophosphamidecytarabinedexamethasone+4 more
Intrathecal Rituximab in Treating Patients With Recurrent CNS Lymphoma
COMPLETEDNCT00416923·PHASE1·University of California, San Francisco·10 enrolled
rituximab
10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
COMPLETEDNCT00052442·PHASE1 / PHASE2·Spectrum Pharmaceuticals, Inc·72 enrolled
pralatrexate
Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer
COMPLETEDNCT00255710·PHASE1·Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins·60 enrolled
filgrastimcyclophosphamidefludarabine phosphatemycophenolate mofetiltacrolimus+3 more
Rituximab Maintenance Therapy in Aggressive CD20 (Cluster of Differentiation Antigen 20) Positive Lymphoma and Mantle Cell Lymphoma
UNKNOWNNCT01933711·PHASE3·University Hospital Heidelberg·328 enrolled
rituximab
Thalidomide and Docetaxel in Treating Patients With Advanced Cancer
COMPLETEDNCT00049296·PHASE1·Case Comprehensive Cancer Center·26 enrolled
docetaxelthalidomide
UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma
COMPLETEDNCT00045500·PHASE1·National Cancer Institute (NCI)
7-hydroxystaurosporineprednisone
Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia
COMPLETEDNCT00053157·NA·Roswell Park Cancer Institute·10 enrolled
sargramostim
Rituximab, Carmustine; Cytarabine, Etoposide, & Melphalan; Stem Cell Transplantation for Non-Hodgkin's Lymphoma
COMPLETEDNCT00080886·PHASE2·University of Nebraska·68 enrolled
rituximabcarmustinecytarabineetoposidemelphalan+2 more
Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia
COMPLETEDNCT00054236·PHASE1·Case Comprehensive Cancer Center·55 enrolled
anti-thymocyte globulinfilgrastimcyclophosphamidefludarabine phosphateumbilical cord blood transplantation+1 more
A Structured Walking Program or Standard Therapy in Cancer Patients Undergoing a Donor Bone Marrow Transplant
COMPLETEDNCT00445731·NA·University of Minnesota·115 enrolled
exercise interventionmanagement of therapy complicationsobservation
Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma
COMPLETEDNCT00038623·PHASE2·M.D. Anderson Cancer Center·35 enrolled
Yttrium-ibritumomab (Zevalin)Rituximab
Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer
TERMINATEDNCT00062231·NA·European Organisation for Research and Treatment of Cancer - EORTC·351 enrolled
amoxicillin-clavulanate potassiumciprofloxacinmoxifloxacin hydrochloridemanagement of therapy complications
Pyroxamide in Treating Patients With Advanced Cancer
COMPLETEDNCT00042900·PHASE1·Memorial Sloan Kettering Cancer Center
pyroxamide
VEGF Trap in Treating Patients With Solid Tumors or Non-Hodgkin's Lymphoma
COMPLETEDNCT00045266·PHASE1·Regeneron Pharmaceuticals
ziv-aflibercept
Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation
COMPLETEDNCT00045292·PHASE3·Fred Hutchinson Cancer Center
acycloviracyclovir sodiumvalacyclovir
CCI-779 in Treating Patients With Mantle Cell Non-Hodgkin's Lymphoma
COMPLETEDNCT00033267·PHASE2·National Cancer Institute (NCI)·27 enrolled
temsirolimus
Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
COMPLETEDNCT00053768·PHASE3·German High-Grade Non-Hodgkin's Lymphoma Study Group·392 enrolled
filgrastimEPOCH regimencyclophosphamidedoxorubicin hydrochlorideetoposide+3 more
CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy
COMPLETEDNCT00031941·PHASE1·National Institutes of Health Clinical Center (CC)
lenalidomide
Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
COMPLETEDNCT00040950·PHASE1·Jonsson Comprehensive Cancer Center
rituximabagatolimod sodium
Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients
COMPLETEDNCT00082654·NA·Fred Hutchinson Cancer Center
psychosocial assessment and care
Treatment of Mantle Cell Lymphoma at Diagnosis for Patients Under 65 Years
COMPLETEDNCT00285389·PHASE2·French Innovative Leukemia Organisation·39 enrolled
AdriblastindexamethasoneChlorambucilrituximabcyclophosphamide+3 more
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer
COMPLETEDNCT00036790·PHASE1·University of Wisconsin, Madison
doxorubicin hydrochloridemotexafin gadolinium
Monoclonal Antibody Therapy in Relapsed Non-Hodgkin's After Chemotherapy and Autologous Stem Cell Transplantation
COMPLETEDNCT00031642·PHASE1 / PHASE2·University of Nebraska·26 enrolled
rituximabyttrium Y 90 ibritumomab tiuxetan
Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer
COMPLETEDNCT00049504·PHASE2·Fred Hutchinson Cancer Center·53 enrolled
cyclophosphamidefludarabine phosphatetacrolimusmycophenolate mofetilpolymerase chain reaction+6 more
Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
WITHDRAWNNCT00301912·PHASE2·University of California, San Francisco
filgrastimbusulfanfludarabine phosphatemethotrexatetacrolimus+3 more